Kristina Sonnevi

485 total citations
25 papers, 177 citations indexed

About

Kristina Sonnevi is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Kristina Sonnevi has authored 25 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 8 papers in Genetics and 8 papers in Oncology. Recurrent topics in Kristina Sonnevi's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (8 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Kristina Sonnevi is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (8 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Kristina Sonnevi collaborates with scholars based in Sweden, Denmark and Finland. Kristina Sonnevi's co-authors include Björn E. Wahlin, Gerd Lärfars, Mats Jerkeman, Karin E. Smedby, Margareta Holmström, Birgitta Sander, Annica Bergendal, Gunilla Enblad, Helle Kieler and Jovan P. Antović and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kristina Sonnevi

24 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Sonnevi Sweden 10 99 79 43 40 30 25 177
Ulises Zanetto United Kingdom 6 45 0.5× 31 0.4× 58 1.3× 32 0.8× 7 0.2× 15 151
Othman Salim Akhtar United States 6 39 0.4× 44 0.6× 41 1.0× 39 1.0× 13 0.4× 25 114
Rikke Linnemann Nielsen Denmark 7 25 0.3× 24 0.3× 18 0.4× 13 0.3× 12 0.4× 13 162
Isaac Rhea United States 10 22 0.2× 51 0.6× 28 0.7× 22 0.6× 29 1.0× 22 280
Angela Giovanna Congiu Italy 6 63 0.6× 52 0.7× 36 0.8× 36 0.9× 18 149
M Luoni Italy 9 64 0.6× 53 0.7× 50 1.2× 25 0.6× 14 219
Anmol Baranwal United States 6 11 0.1× 26 0.3× 65 1.5× 130 3.3× 10 0.3× 24 196
Maja Bech Juul Denmark 5 167 1.7× 95 1.2× 38 0.9× 11 0.3× 11 208
Yasuhiro Taniguchi Japan 10 40 0.4× 23 0.3× 38 0.9× 34 0.8× 4 0.1× 34 224
R Bassan Italy 7 56 0.6× 52 0.7× 44 1.0× 180 4.5× 2 0.1× 20 243

Countries citing papers authored by Kristina Sonnevi

Since Specialization
Citations

This map shows the geographic impact of Kristina Sonnevi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Sonnevi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Sonnevi more than expected).

Fields of papers citing papers by Kristina Sonnevi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Sonnevi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Sonnevi. The network helps show where Kristina Sonnevi may publish in the future.

Co-authorship network of co-authors of Kristina Sonnevi

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Sonnevi. A scholar is included among the top collaborators of Kristina Sonnevi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Sonnevi. Kristina Sonnevi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meriranta, Leo, Arne Kolstad, Martin Hutchings, et al.. (2025). Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma. Blood Advances. 9(17). 4528–4541. 1 indexed citations
2.
Ekberg, Sara, Ingrid Glimelius, Fredrik Ellin, et al.. (2025). Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018. HemaSphere. 9(1). e70080–e70080. 1 indexed citations
3.
Jerkeman, Mats, Karin Mellgren, Kristina Sonnevi, et al.. (2025). Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden. Leukemia. 39(5). 1256–1259.
4.
Vose, Julie M., Umberto Vitolo, Pieternella J. Lugtenburg, et al.. (2024). EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL.. Journal of Clinical Oncology. 42(16_suppl). 7015–7015. 9 indexed citations
5.
Ren, Weicheng, Hui Wan, Mattias Berglund, et al.. (2023). Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia. 38(3). 610–620. 9 indexed citations
6.
Wasik, Agata M., et al.. (2023). 2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia. Cancers. 15(5). 1585–1585. 4 indexed citations
7.
Jerkeman, Mats, Arne Kolstad, Martin Hutchings, et al.. (2023). MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood Advances. 8(2). 407–415. 9 indexed citations
8.
Sonnevi, Kristina, et al.. (2023). Splenic marginal zone lymphoma in Sweden 2000–2020: Increasing rituximab use and better survival in the elderly. SHILAP Revista de lepidopterología. 4(3). 647–655. 2 indexed citations
9.
Haider, Z., Tove Wästerlid, Leily Rabbani, et al.. (2023). Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study. Frontiers in Oncology. 13. 1176698–1176698. 5 indexed citations
10.
Eloranta, Sandra, Sara Ekberg, Gunilla Enblad, et al.. (2022). Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients. British Journal of Haematology. 198(2). 267–277. 20 indexed citations
11.
Wahlin, Björn E., et al.. (2022). Rituximab Infusion in 30 Minutes’ Is Safe and Improves the Flow of Outpatients with Lymphoma Treatment (SPEEDR). Blood. 140(Supplement 1). 10790–10790. 2 indexed citations
12.
Wasik, Agata M., Georgios Panagiotidis, Olof Beck, et al.. (2022). Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 63(6). 1387–1397. 6 indexed citations
13.
14.
15.
Eskelund, Christian Winther, Konstantinos Dimopoulos, Arne Kolstad, et al.. (2020). Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3. HemaSphere. 5(1). e510–e510. 17 indexed citations
16.
Carlsten, Mattias, Martin Jädersten, Karin Littmann, et al.. (2019). The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016. Experimental Hematology and Oncology. 8(1). 7–7. 11 indexed citations
17.
Wasik, Agata M., et al.. (2018). Cannabinoid Receptors and CXCR4 Cross-Talk in Lymphoma Cells. Blood. 132(Supplement 1). 4121–4121. 1 indexed citations
18.
Sonnevi, Kristina, et al.. (2014). Risk factors for recurrent venous thromboembolism in young and middle-aged women. Thrombosis Research. 133(5). 762–767. 12 indexed citations
19.
Sonnevi, Kristina, Svetlana Tchaikovski, Margareta Holmström, et al.. (2013). Obesity and thrombin-generation profiles in women with venous thromboembolism. Blood Coagulation & Fibrinolysis. 24(5). 547–553. 21 indexed citations
20.
Sonnevi, Kristina, Annica Bergendal, Johanna Adami, Gerd Lärfars, & Helle Kieler. (2013). Self-reported family history in estimating the risk of hormone, surgery and cast related VTE in women. Thrombosis Research. 132(2). 164–169. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulises Zanetto Breakdown of academic impact, for papers by Othman Salim Akhtar Breakdown of academic impact, for papers by Rikke Linnemann Nielsen Breakdown of academic impact, for papers by Isaac Rhea Breakdown of academic impact, for papers by Angela Giovanna Congiu Breakdown of academic impact, for papers by M Luoni Breakdown of academic impact, for papers by Anmol Baranwal Breakdown of academic impact, for papers by Maja Bech Juul Breakdown of academic impact, for papers by Yasuhiro Taniguchi Breakdown of academic impact, for papers by R Bassan
Rankless by CCL
2026